However, a growing number of evidence show that ligand activation of GPCR can also induce transactivation of EGFR in various cancer cells, which represent an important mechanism of regulating both GPCR- and EGFR-mediated tumor progression [14–18]. This evidence concerns the gene EGFR and cancer.